Supplemental material
Global Health Action
Volume 11, 2018 - Issue 1
Original Article
Time to anti-retroviral therapy among people living with HIV enrolled into care in Myanmar: how prepared are we for ‘test and treat’?
, 
, , , &
Hemant Deepak ShewadeInternational Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Office, New Delhi, India;International Union Against Tuberculosis and Lung Disease (The Union), Paris, Francehttp://orcid.org/0000-0002-8242-1911View further author information
http://orcid.org/0000-0002-8242-1911View further author information, , Thae Maung MaungDepartment of Medical Research, Yangon Head Quarter, Myanmarhttp://orcid.org/0000-0002-1265-3813View further author information
http://orcid.org/0000-0002-1265-3813View further author information, & Related Research Data
Delayed entry into HIV medical care in a nationally representative sample of HIV-infected adults receiving medical care in the USA.
Source:
Informa UK Limited
A Cohort Analysis of Retention After Scale-Up
Source:
Ovid Technologies (Wolters Kluwer Health)
Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care.
Source:
Informa UK Limited
Factors Associated with a Delay in Seeking HIV/AIDS Treatment in São Paulo, Brazil
Source:
Springer Science and Business Media LLC
Delayed entry into HIV care after diagnosis in two specialized care and treatment centres in Cameroon: the influence of CD4 count and WHO staging.
Source:
Springer Science and Business Media LLC
Linking provided by
